<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0"><channel><atom:id>tag:blogger.com,1999:blog-510410376109552611</atom:id><lastBuildDate>Fri, 08 Jul 2011 09:30:36 +0000</lastBuildDate><category>Maurice Greenberg</category><category>The Journal of Accountancy</category><category>Private Insurance</category><category>Investor relations</category><category>Climate change accounting</category><category>complimentary webinar</category><category>SEC Division of Corporate Finance</category><category>Tax compliance</category><category>CFO</category><category>gorman health group</category><category>Hits</category><category>San Diego</category><category>Happy Holidays from Pharma Dollars and Sense</category><category>IFRS Roadmap</category><category>Pension plans</category><category>Accounting methods</category><category>vermont government</category><category>Mary Schapiro</category><category>Forbes</category><category>China Daily</category><category>IASB</category><category>Chief Accounting Officer</category><category>Global Accounting Alliance</category><category>Accounting Principles</category><category>Accountants</category><category>Healthcare Investment Transactions Summit</category><category>Deloitte and Touche</category><category>Off balance vehicle sheets</category><category>Sir David Tweedie</category><category>Glogbal accounting standards</category><category>Research and development</category><category>International Accounting Standards Board</category><category>pharma</category><category>Value of assets</category><category>welcome</category><category>Budget cuts</category><category>Pharma Financial Forum</category><category>Consumer Financial Protection Agency</category><category>Impact Assesment</category><category>Accounting Charge</category><category>Fair Market Value Rules</category><category>Zenei Cortez</category><category>IFRS USA</category><category>Fair Value Accounting</category><category>medicare congress</category><category>Equipment leasing</category><category>Bob Hertz</category><category>Accounting interpretations</category><category>Insurance contracts</category><category>Grant Thorton study</category><category>Dennis Howlett</category><category>Public Company Accounting Oversight Board</category><category>Federal regulators</category><category>Computer World</category><category>Mark to Market</category><category>Valuation Research Corp</category><category>FEI Canada</category><category>California Progress Report</category><category>Lawsuit disclosures and accounting</category><category>CFERF</category><category>Wall Street Journal</category><category>Bankruptcy</category><category>National Income accounting</category><category>Neil Cotty</category><category>Obama</category><category>Credit crisis</category><category>new york</category><category>Earnst and Young</category><category>pharma news</category><category>Tenent Healthcare Corporation</category><category>new york times</category><category>Loan accounting</category><category>Jaguar</category><category>Early adopters</category><category>IFRS Adoption</category><category>Financial Crisis Advisory Board</category><category>Cashflow</category><category>SEC Chairman</category><category>Face to face social networks</category><category>Financial accounting</category><category>Pharma Accounting</category><category>IT changes</category><category>IRS</category><category>webinar news</category><category>Reducing costs</category><category>Contingent liabilities</category><category>GASP</category><category>Topic 820</category><category>Patient volumes</category><category>Brazil</category><category>Accounting obligations</category><category>Training for new accounting system</category><category>Accounting rules</category><category>Public companies coverting to IFRS</category><category>Business cell phones</category><category>Mark Olson</category><category>Bloomberg</category><category>Increasing savings</category><category>finance</category><category>FAS 157</category><category>medicare news</category><category>Changing accounting rules in a recession</category><category>doctors</category><category>Doug Shulman</category><category>Accounting Standards</category><category>Joint Ventures</category><category>Accounting rule changes</category><category>Audit Integrity</category><category>Market to market accounting</category><category>Financial health</category><category>US Audit Industry</category><category>Lenders</category><category>Global recession</category><category>Banks</category><category>pharma dollars and sense</category><category>KPMG</category><category>Social Network</category><category>Universal Accounting Standards</category><category>Converting to IFRS</category><category>Ambient</category><category>drug companies</category><category>PJ Patel</category><category>Lawyers</category><category>Accounting</category><category>Operating cash flow</category><category>Property leasing</category><category>IFRS accounting system</category><category>JRG VEntures</category><category>Pension Accounting</category><category>GAAP</category><category>Chief Accountant</category><category>healthcare industry</category><category>Transparent Accounting System</category><category>Carbon Accounting</category><category>Accounting social network</category><category>Tata Motors</category><category>Pharma Taxes</category><category>FASB</category><category>PennLive</category><category>Lawsuit accounting</category><category>Pricewaterhouse Coopes</category><category>Investment management firm</category><category>Market prices accounting</category><category>Indiana State Government</category><category>CPAs knowledge of IFRS</category><category>Income taxes</category><category>ar</category><category>Retirement Plans</category><category>Reuters</category><category>Taxes</category><category>State Accounting records</category><category>Eric Hespenheide</category><category>Wayne Carnall</category><category>AICPA Trends Report</category><category>Earnings stripping</category><category>IFRS accounting sstem</category><category>WebCPA</category><category>IFRS</category><category>Private accounting</category><category>Malcolm McKay</category><category>Pensions and Investments</category><category>Accounting degrees</category><category>Paul Cherry</category><category>Governmental Accouting Standards Board</category><category>BizTimes</category><category>Accountin gmasters</category><category>Second quarter 2009 returns</category><category>American International Group</category><category>Fierce Healthcare</category><category>Yahoo</category><category>Governmental accounting</category><category>Valor Economico</category><category>The Economist</category><category>SEC Chief Accountant</category><category>European Federation of Accountancy Bodies</category><category>tax barriers overseas</category><category>Vancouver Sun</category><category>Americas Health Insuranc Plans</category><category>James Kroeker</category><category>Fiduciary accounting</category><category>Public accounting</category><category>Accounting system change</category><category>Deloitte Touche Tohmatsu</category><category>healthcare news</category><category>Plant leasing</category><category>Bank of America</category><category>Canadian Accounting</category><category>principle based accounting</category><category>International Accounting</category><category>Global wealth investment</category><category>Pharma Finance</category><category>Cost of adopting IFRS</category><category>Germany</category><category>International accounting matters</category><category>Cell phone taxes</category><category>balance sheets</category><category>Securities and Exchange Commission</category><category>sarah rubenstein</category><category>Lease accounting</category><category>Professional Accounting Practice Issues</category><category>Medicaid Drug Rebate Program</category><category>Land Rover</category><category>US GAAP</category><category>Regulatory requirements</category><category>Audit</category><title>Pharma Dollars and Sense</title><description>A look at accounting and finance issues, techniques, and challenges within the Pharmaceutical and BioTech industries.</description><link>http://pharmadollarsandsense.blogspot.com/</link><managingEditor>noreply@blogger.com (Jennifer)</managingEditor><generator>Blogger</generator><openSearch:totalResults>53</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/PharmaDollarsAndSense" /><feedburner:info uri="pharmadollarsandsense" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>PharmaDollarsAndSense</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5763791205733591277</guid><pubDate>Fri, 25 Dec 2009 11:00:00 +0000</pubDate><atom:updated>2009-12-25T06:00:02.780-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Happy Holidays from Pharma Dollars and Sense</category><title>Happy Holidays from Pharma Dollars and Sense</title><atom:summary>We're taking some much needed time off from our coverage of Pharma to celebrate the season with our loved ones. We want to sincerely thank you for your readership, your comments and your participation.  Here are our highest rated articles from 2009:  Pharma Dollars and Sense: Will principle based accounting improve financial reporting?Pharma Dollars and Sense: IFRS versus US GAAPPharma Dollars </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/T1UDh-An2rU/happy-holidays-from-pharma-dollars-and.html</link><author>noreply@blogger.com (Melissa)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/T1UDh-An2rU" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/12/happy-holidays-from-pharma-dollars-and.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2183563060673073529</guid><pubDate>Mon, 14 Dec 2009 15:43:00 +0000</pubDate><atom:updated>2009-12-14T10:48:18.122-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">gorman health group</category><category domain="http://www.blogger.com/atom/ns#">medicare congress</category><category domain="http://www.blogger.com/atom/ns#">Medicaid Drug Rebate Program</category><category domain="http://www.blogger.com/atom/ns#">complimentary webinar</category><category domain="http://www.blogger.com/atom/ns#">medicare news</category><title>Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group</title><atom:summary>Space is limited.Reserve your Webinar seat now at:https://www1.gotomeeting.com/register/504426600Mention Priority code: P1507W1BLOGJohn Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans including the financial, </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/SZFTyQNsniE/complimentary-webinar-assessing-impact_14.html</link><author>noreply@blogger.com (Melissa)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/SZFTyQNsniE" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/12/complimentary-webinar-assessing-impact_14.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8423164321587837561</guid><pubDate>Wed, 09 Dec 2009 15:18:00 +0000</pubDate><atom:updated>2009-12-09T10:25:25.770-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">healthcare industry</category><category domain="http://www.blogger.com/atom/ns#">Hits</category><category domain="http://www.blogger.com/atom/ns#">JRG VEntures</category><category domain="http://www.blogger.com/atom/ns#">Ambient</category><category domain="http://www.blogger.com/atom/ns#">Healthcare Investment Transactions Summit</category><title>Healthcare Investment &amp; Transaction Summit, New York City - Early Bird Ends This Friday, December 11</title><atom:summary>IIR’s Healthcare Investment &amp; Transaction Summit (HITS), now taking place on January 28-29, 2010 in New York City, is the deal-making industry event of the year! Join us today and be one of the many to benefit from the year’s most prestigious healthcare deal-making event. HITS brings together the industry’s financial giants, with buyers and sellers, and the brokers who connect them and the </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/PRbwjLnT8G4/healthcare-investment-transaction.html</link><author>noreply@blogger.com (Thiago)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/PRbwjLnT8G4" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/12/healthcare-investment-transaction.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-408901955509547372</guid><pubDate>Tue, 08 Dec 2009 16:09:00 +0000</pubDate><atom:updated>2009-12-08T11:11:42.769-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">healthcare news</category><category domain="http://www.blogger.com/atom/ns#">healthcare industry</category><category domain="http://www.blogger.com/atom/ns#">webinar news</category><category domain="http://www.blogger.com/atom/ns#">complimentary webinar</category><category domain="http://www.blogger.com/atom/ns#">pharma news</category><title>Complimentary Webinar: Assessing the Impact of Healthcare Reform on the Business of Medicare: An Interview with Gorman Health Group</title><atom:summary>December 15, 20092-3PM ESTSpace is limited.Reserve your Webinar seat now at:https://www1.gotomeeting.com/register/504426600Mention Priority Code: P1507W1BLOGJohn Gorman, CEO, Gorman Health Group, along with Jean LeMasurier, Senior Vice President, Public Policy, Gorman Health Group will examine the current state of US healthcare reform, and its short and long term impact on Medicare plans </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/VgGhuy4MsCQ/complimentary-webinar-assessing-impact.html</link><author>noreply@blogger.com (Melissa)</author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_8x7slURffAI/Sx5vr1Ce3eI/AAAAAAAAAjk/WI6q7Cs325c/s72-c/jean_09.jpg" height="72" width="72" /><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/VgGhuy4MsCQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/12/complimentary-webinar-assessing-impact.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5003242446710613359</guid><pubDate>Mon, 07 Dec 2009 16:59:00 +0000</pubDate><atom:updated>2009-12-07T12:12:19.011-05:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Zenei Cortez</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">California Progress Report</category><category domain="http://www.blogger.com/atom/ns#">Americas Health Insuranc Plans</category><category domain="http://www.blogger.com/atom/ns#">Private Insurance</category><category domain="http://www.blogger.com/atom/ns#">Healthcare Investment Transactions Summit</category><title>Health care reform: Private Insurers paying for federal lobbying</title><atom:summary>A recent article written by Zenei Cortez at the California Progress Report looks at how the current finances in the health care industry are being geared towards federal lobbying.  In fact, the article state that the nation's top 13 private health insurers and their trade group, America's Health Insurance Plans (AHIP) spent nearly $23  million  in federal lobbying to tilt reform in their </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/g9augNqUXOM/health-care-reform-private-insurers.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/g9augNqUXOM" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/12/health-care-reform-private-insurers.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-1334542166431425880</guid><pubDate>Tue, 15 Sep 2009 18:28:00 +0000</pubDate><atom:updated>2009-09-15T14:32:51.887-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">International Accounting Standards Board</category><category domain="http://www.blogger.com/atom/ns#">Federal regulators</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Global recession</category><title>Adopting IFRS Key to global financial success</title><atom:summary>According to the Associated Press, federal regulators stated Monday that it's critical for the United States along with other countries to adopt one international accounting standard.  By all countries having the same policies, we would better avoid another economic crisis.  Both those on Wall Street and in the Accounting industry agree with this statement.  US companies have the option to begin </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/zHqYJIacmv0/adopting-ifrs-key-to-global-financial.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/zHqYJIacmv0" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/09/adopting-ifrs-key-to-global-financial.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7288936642934576658</guid><pubDate>Fri, 04 Sep 2009 14:43:00 +0000</pubDate><atom:updated>2009-09-04T10:47:16.046-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Topic 820</category><category domain="http://www.blogger.com/atom/ns#">Wall Street Journal</category><category domain="http://www.blogger.com/atom/ns#">FAS 157</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Mark to Market</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>Name Change for FAS 157</title><atom:summary>The Wall Street Journal Blog recently wrote about the name change for FAS 157.  It will now be known as Topic 820.  This rule currently requires companies mark their assets to market every quarter.  With the old rule, the assets were held at cost.  Read more about the name and rule change here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/MSSduAlPqAU/name-change-for-fas-157.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/MSSduAlPqAU" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/09/name-change-for-fas-157.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8551593417154199798</guid><pubDate>Tue, 01 Sep 2009 20:03:00 +0000</pubDate><atom:updated>2009-09-01T16:08:04.201-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting system change</category><category domain="http://www.blogger.com/atom/ns#">Training for new accounting system</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Indiana State Government</category><title>Indiana Government converting to centralized accounting system</title><atom:summary>According to Fox 28 of South Bend, Indiana, the Hoosier government will be converting to one single accounting system.  The complete transition will take place by September 16.  This has been in the works for years, and over 3,000 state employees have been trained on the new system.  Read the full article here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/Y1wCCiFvXDc/indiana-government-converting-to.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/Y1wCCiFvXDc" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/09/indiana-government-converting-to.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8831067284642050083</guid><pubDate>Thu, 27 Aug 2009 14:16:00 +0000</pubDate><atom:updated>2009-08-27T10:20:23.726-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">SEC Chief Accountant</category><category domain="http://www.blogger.com/atom/ns#">James Kroeker</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">Mary Schapiro</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Securities and Exchange Commission</category><title>What does Kroeker’s appointment mean for IFRS?</title><atom:summary>On Tuesday, the Securities and Exchange Commission appointed James L. Kroeker the permanent chief accountant at the agency.  Many in the industry thought SEC’s Mary Schapiro would select someone with a little more resistance to IFRS.  How will the industry respond to a big four Chief Accountant?  And most importantly, what does Kroeker’s appointment mean for the timelines surrounding IFRS </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/aXYhpINSuN8/what-does-kroekers-appointment-mean-for.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/aXYhpINSuN8" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/what-does-kroekers-appointment-mean-for.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7813821023529317733</guid><pubDate>Wed, 26 Aug 2009 16:02:00 +0000</pubDate><atom:updated>2009-08-26T12:07:39.229-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">SEC Chief Accountant</category><category domain="http://www.blogger.com/atom/ns#">James Kroeker</category><category domain="http://www.blogger.com/atom/ns#">Accounting interpretations</category><category domain="http://www.blogger.com/atom/ns#">International accounting matters</category><category domain="http://www.blogger.com/atom/ns#">Chief Accountant</category><category domain="http://www.blogger.com/atom/ns#">Professional Accounting Practice Issues</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>James L. Kroeker becomes SEC's permanent cheif accountant</title><atom:summary>The Wall Street Journal stated that James L. Kroeker will become the permanent chief accountant for the Securities and Exchange Commission.  He has been serving as the chief accountant since January.  He will be overseeing accounting interpretations, professional practice issues and international accounting matters.How do you think Kroeker's new position will affect the United States and it's </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/VVLWlJ7iEtY/james-l-kroeker-becomes-secs-permanent.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/VVLWlJ7iEtY" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/james-l-kroeker-becomes-secs-permanent.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-3780108578179553203</guid><pubDate>Mon, 24 Aug 2009 18:42:00 +0000</pubDate><atom:updated>2009-08-24T14:44:51.223-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">The Journal of Accountancy</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Converting to IFRS</category><category domain="http://www.blogger.com/atom/ns#">GAAP</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">IT changes</category><title>Controlling your risk when converting to IFRS</title><atom:summary>The Journal Of Accountancy recently published a post that looks at how companies can take precautions when it comes to converting from GAAP to IFRS.  One of the key areas that will be affected during the conversion will be IT, as many of the systems will be changing due to the new accounting methods.  Read the full article here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/G4KEA6eaMlk/controlling-your-risk-when-converting.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/G4KEA6eaMlk" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/controlling-your-risk-when-converting.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-1922453500359699579</guid><pubDate>Thu, 20 Aug 2009 21:24:00 +0000</pubDate><atom:updated>2009-08-20T17:30:21.487-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Lawsuit disclosures and accounting</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">Lawsuit accounting</category><category domain="http://www.blogger.com/atom/ns#">CFO</category><title>FASB's changes on disclosing private information</title><atom:summary>According to CFO, there is debate as to how companies are handling lawsuits and their accounting rules and disclosures.  Under the new rules of FASB, companies would not have to disclose any information that they feel is prejudicial or confidential.  This would include not disclosing any information about the money they pay to investors to settle disagreements. Last September, when the board </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/mF2m9vPkX-0/fasbs-changes-on-disclosing-private.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/mF2m9vPkX-0" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/fasbs-changes-on-disclosing-private.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2385565812206053259</guid><pubDate>Wed, 19 Aug 2009 16:25:00 +0000</pubDate><atom:updated>2009-08-19T12:33:55.403-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">IFRS Adoption</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Glogbal accounting standards</category><category domain="http://www.blogger.com/atom/ns#">Credit crisis</category><category domain="http://www.blogger.com/atom/ns#">Transparent Accounting System</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Reuters</category><title>Adopting IFRS slowing</title><atom:summary>In an article recently at Reuters India, they look at how the current global economy is just one of the latest factors holding up the adoption of IFRS globally.  Due to the credit crisis, many countries have seen the need to adopt a more consistent and transparent accounting system.  However, with the US failing to provide a date as to when they'll be adopting the system.  The G20 Finance </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/-PVdQI-rjws/adopting-ifrs-slowing.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>1</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/-PVdQI-rjws" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/adopting-ifrs-slowing.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7019213770250179287</guid><pubDate>Mon, 17 Aug 2009 19:04:00 +0000</pubDate><atom:updated>2009-08-17T15:45:53.641-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Fair Market Value Rules</category><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">Bloomberg</category><category domain="http://www.blogger.com/atom/ns#">Accounting</category><title>Fair market value rules may expand</title><atom:summary>According to Bloomberg, last week, FASB decided to consider expanding fair market value rules.  Accountants could end up expanding mark-to-market across all financial assets.  Read the full article here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/gQmkhHrZRss/fair-market-value-rules-may-expand.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/gQmkhHrZRss" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/fair-market-value-rules-may-expand.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-735856939592169510</guid><pubDate>Tue, 11 Aug 2009 20:51:00 +0000</pubDate><atom:updated>2009-08-11T16:54:32.777-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Lenders</category><category domain="http://www.blogger.com/atom/ns#">Social Network</category><category domain="http://www.blogger.com/atom/ns#">Lawyers</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Face to face social networks</category><category domain="http://www.blogger.com/atom/ns#">Accounting social network</category><category domain="http://www.blogger.com/atom/ns#">Accountants</category><title>New network for accountants</title><atom:summary>A new social network for accountants has been launched.  Hub Street is a social network that brings together accountants, lawyers, and lenders to create connections in the industries.  It also has a unique aspect for social networks.Fox Coaching Associates CEO Nancy Fox explains, “Let’s face it – it’s not what you know, but who you know.  Unlike most online and face-to-face networks, HubStreet </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/rfWZYy8tL3k/new-network-for-accountants.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/rfWZYy8tL3k" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/new-network-for-accountants.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-5294563270853661791</guid><pubDate>Mon, 10 Aug 2009 17:50:00 +0000</pubDate><atom:updated>2009-08-10T13:54:42.399-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Accounting Charge</category><category domain="http://www.blogger.com/atom/ns#">Maurice Greenberg</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">American International Group</category><title>Former AIG Executive settling accounting charge</title><atom:summary>Maurice "Hank" Greenberg, Former American International Group Chief Executive, will pay $15 million to settle an accounting charge. According to the article,Greenberg and Smith were responsible for "material misstatements" that helped AIG create the false impression that the insurer had consistently met or exceeded key earnings and growth targets, the SEC claimed.Read the full article here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/hr_eSeD3QFs/former-aig-executive-settling.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/hr_eSeD3QFs" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/former-aig-executive-settling.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-8653056964136794060</guid><pubDate>Wed, 05 Aug 2009 18:30:00 +0000</pubDate><atom:updated>2009-08-05T14:41:40.058-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">US GAAP</category><category domain="http://www.blogger.com/atom/ns#">Early adopters</category><category domain="http://www.blogger.com/atom/ns#">SEC Chairman</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Cost of adopting IFRS</category><title>How are you handling the transition to IFRS standards?</title><atom:summary>The SEC estimates the transition from US GAAP to IFRS will cost each early adopter $32 million over the first three years. Although the convergence for large accelerated manufacturers doesn’t occur until 2014, you can start reducing your $32 million spend by planning for a smooth, timely transition today.• Have you planned for the cost associated with transitioning to IFRS?• Do you understand the</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/KjuBgM5Xckg/how-are-you-handling-transition-to-ifrs.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/KjuBgM5Xckg" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/how-are-you-handling-transition-to-ifrs.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-6956460442333272834</guid><pubDate>Wed, 05 Aug 2009 15:53:00 +0000</pubDate><atom:updated>2009-08-05T12:02:19.871-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Bob Hertz</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">IFRS Roadmap</category><category domain="http://www.blogger.com/atom/ns#">US GAAP</category><category domain="http://www.blogger.com/atom/ns#">Mary Schapiro</category><category domain="http://www.blogger.com/atom/ns#">Sir David Tweedie</category><category domain="http://www.blogger.com/atom/ns#">SEC Chairman</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">European Federation of Accountancy Bodies</category><title>Tweedie encourages US to join IFRS</title><atom:summary>At WebCPA, they divulge that Sir David Tweedie has encouraged the United States to come up with an adoption plan for IFRS.  Although Tweeide has and FASB Chairman Bob Hertz have worked closely together to weave US GAAP into IFRS, the new leader of the SEC, Mary Schapiro has not said whether or not she has approved of the latest model of the roadmap to adoption. During the American Accounting </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/WRHNGGkYeK8/tweedie-encourages-us-to-join-ifrs.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/WRHNGGkYeK8" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/tweedie-encourages-us-to-join-ifrs.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2349342941124202815</guid><pubDate>Mon, 03 Aug 2009 19:13:00 +0000</pubDate><atom:updated>2009-08-03T15:18:37.541-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">IFRS</category><category domain="http://www.blogger.com/atom/ns#">Converting to IFRS</category><category domain="http://www.blogger.com/atom/ns#">GAAP</category><category domain="http://www.blogger.com/atom/ns#">CPAs knowledge of IFRS</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><title>CPAs knowledge in IFRS and GAAP</title><atom:summary>The IFRS blog recently asked if your CPA was bilingual.  Although the United States has not yet fully committed to adopting IFRS, many other countries throughout the world have begun to take the steps to adopt this new worldwide accounting system.  EM sees a new state of accounting in 2012, that where either the US has adopted IFRS or an accounting world where IFRS and GAAP coexist.  So, he </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/tIJh-4ewSic/cpas-knowledge-in-ifrs-and-gaap.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/tIJh-4ewSic" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/08/cpas-knowledge-in-ifrs-and-gaap.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-739314784952075429</guid><pubDate>Thu, 30 Jul 2009 20:39:00 +0000</pubDate><atom:updated>2009-07-30T16:44:13.941-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Reducing costs</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Tenent Healthcare Corporation</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Fierce Healthcare</category><category domain="http://www.blogger.com/atom/ns#">Patient volumes</category><category domain="http://www.blogger.com/atom/ns#">Second quarter 2009 returns</category><title>Tenent Healthcare Corp improves returns</title><atom:summary>According to Fierce Healthcare, Tenent Healthcare Corporation has posted better returns than previously expected for the second quarter.  By holding down costs, offsetting growing bad debts, and lowering patient volumes they managed to push revenue up 4.5% and improve their free cash flow.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/Oq0ZoSJoA7o/tenent-healthcare-corp-improves-returns.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/Oq0ZoSJoA7o" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/tenent-healthcare-corp-improves-returns.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7659727541888724550</guid><pubDate>Wed, 29 Jul 2009 16:33:00 +0000</pubDate><atom:updated>2009-07-29T12:37:02.278-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">The Journal of Accountancy</category><category domain="http://www.blogger.com/atom/ns#">Accountin gmasters</category><category domain="http://www.blogger.com/atom/ns#">AICPA Trends Report</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Accounting degrees</category><title>Number of accounting degrees is up</title><atom:summary>According to an article at The Journal of Accountancy, 66,000 Masters or Bachelors degrees were awarded to accounting graduates in the 2007-2008 school year.  This is up 3.5% from the 2006-2007 academic year.  Read some of the other findings in the AICPA 2009 Trends Report here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/ziw-MHzMva8/number-of-accounting-degrees-is-up.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/ziw-MHzMva8" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/number-of-accounting-degrees-is-up.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-3963845549508490526</guid><pubDate>Tue, 28 Jul 2009 20:31:00 +0000</pubDate><atom:updated>2009-07-28T16:36:38.318-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Credit crisis</category><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">Accounting rules</category><category domain="http://www.blogger.com/atom/ns#">pharma dollars and sense</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Financial Crisis Advisory Board</category><title>Current financial crisis not caused by change in accounting rules</title><atom:summary>According to the AP, The Financial Crisis Advisory Group has stated that changes in accounting rules did not cause the most recent credit crisis.  They did state that there are weaknesses in the application rules that may reduce the credibility in the financial reporting.  To see all of their current views, please read the article here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/1UDJS9Xo6OA/current-financial-crisis-not-caused-by.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/1UDJS9Xo6OA" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/current-financial-crisis-not-caused-by.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-7669892896395544498</guid><pubDate>Mon, 27 Jul 2009 18:40:00 +0000</pubDate><atom:updated>2009-07-27T14:45:11.178-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Tata Motors</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Accounting rule changes</category><category domain="http://www.blogger.com/atom/ns#">Land Rover</category><category domain="http://www.blogger.com/atom/ns#">Jaguar</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Bloomberg</category><title>Tata Motors profits rise after change in accounting rules</title><atom:summary>According to Bloomberg, Tata Motors, who won Jaguar and Land Rover, saw an increase in profit after the Indian government changed accounting rules.  They allowed companies to alter provsions for mark-to-market losses in foreign currency loans.  This resulted in a profit rise of 58%.  Read more here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/vRaKYUuZg94/tata-motors-profits-rise-after-change.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/vRaKYUuZg94" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/tata-motors-profits-rise-after-change.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-4246856374983994330</guid><pubDate>Fri, 24 Jul 2009 19:04:00 +0000</pubDate><atom:updated>2009-07-24T15:09:28.622-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Global wealth investment</category><category domain="http://www.blogger.com/atom/ns#">Chief Accounting Officer</category><category domain="http://www.blogger.com/atom/ns#">Pharma Finance</category><category domain="http://www.blogger.com/atom/ns#">Investment management firm</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">Neil Cotty</category><category domain="http://www.blogger.com/atom/ns#">Bank of America</category><title>Bank of America has new Chief Accounting Officer</title><atom:summary>Yesterday, Neil Cotty was named the new Chief Accounting Officer at Bank of America.  His previous position was chief financial officer at a global wealth and investment management firm.  Read more about their new selection here.</atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/5Api0Bnj_Xw/bank-of-america-has-new-chief.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/5Api0Bnj_Xw" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/bank-of-america-has-new-chief.html</feedburner:origLink></item><item><guid isPermaLink="false">tag:blogger.com,1999:blog-510410376109552611.post-2013889046448832458</guid><pubDate>Wed, 22 Jul 2009 17:50:00 +0000</pubDate><atom:updated>2009-07-22T13:56:23.717-04:00</atom:updated><category domain="http://www.blogger.com/atom/ns#">Property leasing</category><category domain="http://www.blogger.com/atom/ns#">balance sheets</category><category domain="http://www.blogger.com/atom/ns#">Lease accounting</category><category domain="http://www.blogger.com/atom/ns#">Plant leasing</category><category domain="http://www.blogger.com/atom/ns#">Equipment leasing</category><category domain="http://www.blogger.com/atom/ns#">Pharma Financial Forum</category><category domain="http://www.blogger.com/atom/ns#">FASB</category><category domain="http://www.blogger.com/atom/ns#">CFO</category><title>Accouting for leases may change soon</title><atom:summary>An article at CFO updates us on the current progress of an accounting rule that could change the way companies account for leases.  Any company that leases plants, property or equipment would be responsible for FASB predicts this new rule will be in place by 2011.Under the current rule, companies distinguish between capital lease obligations, which appear on the balance sheet, and operating </atom:summary><link>http://feedproxy.google.com/~r/PharmaDollarsAndSense/~3/bwTFKWQ_JiM/accouting-for-leases-may-change-soon.html</link><author>noreply@blogger.com (Jennifer)</author><thr:total>0</thr:total><description>&lt;img src="http://feeds.feedburner.com/~r/PharmaDollarsAndSense/~4/bwTFKWQ_JiM" height="1" width="1"/&gt;</description><feedburner:origLink>http://pharmadollarsandsense.blogspot.com/2009/07/accouting-for-leases-may-change-soon.html</feedburner:origLink></item></channel></rss>

